Klor-con and Renal cell carcinoma - a phase IV clinical study of FDA data

Summary:

Renal cell carcinoma is reported as a side effect among people who take Klor-con (potassium chloride), especially for people who are female, 60+ old, also take Lasix, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Renal cell carcinoma when taking Klor-con. It is created by eHealthMe based on reports of 27,036 people who have side effects when taking Klor-con from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 790 drugs and 1,334 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

On Jul, 15, 2026

27,036 people reported to have side effects when taking Klor-con.
Among them, 56 people (0.21%) have Renal cell carcinoma.

Could Klor-con cause Renal cell carcinoma?

Among these 56 people:

What is the gender of people who have Renal cell carcinoma when taking Klor-con? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Renal cell carcinoma when taking Klor-con? *

What are other drugs people take besides Klor-con? *

What are other side effects people have besides Renal cell carcinoma? *

Cardiac Failure Congestive: 18 people, 32.14%
Fatigue (feeling of tiredness): 15 people, 26.79%
Insomnia (sleeplessness): 14 people, 25.00%
Chest Pain: 14 people, 25.00%
Upper Respiratory Tract Infection: 12 people, 21.43%
Cardiomyopathy (weakening of the heart muscle): 11 people, 19.64%
Pneumonia: 11 people, 19.64%
Enlarged Heart: 11 people, 19.64%
Pleural Effusion (water on the lungs): 11 people, 19.64%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 10 people, 17.86%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 16.07%
Stress And Anxiety: 9 people, 16.07%
Cardiac Failure: 8 people, 14.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 14.29%
Multiple Myeloma (cancer of the plasma cells): 7 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 12.50%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 10.71%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 6 people, 10.71%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 10.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and have Renal cell carcinoma?

- Check whether Renal cell carcinoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Klor-con:

Klor-con (27,547 reports)

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Renal cell carcinoma:

Renal cell carcinoma (790 drugs)

Browse all the conditions that are associated with Renal cell carcinoma:

Renal cell carcinoma (1,334 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of Klor-con) and Klor-con (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.